<H1>EXJADE</H1><P> EXJADE on the basis of its proven efficacy and safety profile in patients with iron toxicity across a wide range of chronic anemias, including β-thalassemia, sickle cell disease, myelodysplastic syndromes, and other anemias.1-4</P>
